Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESTRO 2022 | Intensive follow up for patients with high-risk breast cancer

Icro Meattini • 23 May 2022
ESTRO 2022
Breast Cancer

Icro Meattini, MD, University of Florence, Florence, Italy, discusses which patients with high-risk breast cancer should receive intensive follow-ups. This interview took place at the European Society for Radiotherapy and Oncology (ESTRO) 2022 annual congress in Copenhagen, Denmark, and online.

More from Icro Meattini

2:11
Partial and no radiation in elderly patients with breast cancer
Icro Meattini • 21 Mar 2024
0:40
Innovations in radiation therapy planning
Icro Meattini • 6 Dec 2023
0:40
Innovations in radiation therapy planning
Icro Meattini • 6 Dec 2023
0:50
Patient-friendly radiation courses in breast cancer
Icro Meattini • 6 Dec 2023

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals